• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    59.55 2.07(3.60%) Dec 18, 4:00PM EST
    |Pre-Market : 63.80 Up 4.25 (7.14%) 6:03AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:57.48
    Open:58.66
    Bid:63.80 x 200
    Ask:64.29 x 500
    1y Target Est:55.90
    Beta:1.63
    Earnings Date:Feb 26 - Mar 2 (Est.)
    Day's Range:57.95 - 60.04
    52wk Range:22.25 - 65.13
    Volume:2,147,883
    Avg Vol (3m):2,349,160
    Market Cap:7.04B
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for ISIS

    Comparison

    Symbol% ChgMkt Cap
    ISISUp 3.60%7.04B
    ENZ209.43M
    GILD159.22B
    SRPT570.06M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):39.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.63
    Quarterly EPS Est (Dec-14) :-0.03
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-3.79

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback